CA Patent

CA2706858A1 — Imidazole and triazole derivatives and methods of use

Assigned to Ardea Biociences Inc · Expires 2009-06-04 · 17y expired

What this patent protects

Described herein arc compounds useful in the modulation of blood uric, acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of dis-orders relafed to aberrant levels of uric…

USPTO Abstract

Described herein arc compounds useful in the modulation of blood uric, acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of dis-orders relafed to aberrant levels of uric acid.

Drugs covered by this patent

Patent Metadata

Patent number
CA2706858A1
Jurisdiction
CA
Classification
—
Expires
2009-06-04
Drug substance claim
No
Drug product claim
No
Assignee
Ardea Biociences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.